Nanomedx
PrivateLast Round
Grant
Jun 20, 2025
Total Funding Raised
$1.04M
Company Overview
Nanomedx is a nanomedicine company developing an injectable nanotherapy, delivered via a specialized balloon catheter, to treat peripheral arterial disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Imaging, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanomedx Comps
Public and private peers based on sector, stage, and business model.
Nanomedx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 20, 2025 | ||||
| Grant | Sep 23, 2021 |
Key People
Founding team and executive leadership
Nanomedx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UniQuest Pty Ltd | Grant |
| Bioshore Capital Partners | Grant |
| MTPConnect | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2025
$480K raised from Bioshore Capital Partners and MTPConnect.
- Sep 23, 2021
$560K grant round from Medical Device Partnering Program, MTPConnect, and UniQuest.
Nanomedx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanomedx's valuation, stock price, and market status.
